Related Experiment Videos
Gonadotropin-releasing hormone agonist in a GIFT program.
1Division of Reproductive Endocrinology/Infertility, UMDNJ-RWJMS, New Brunswick 08901.
New Jersey Medicine : the Journal of the Medical Society of New Jersey
|April 1, 1992
Summary
Gamete intrafallopian transfer (GIFT) effectively treats infertility. Using a gonadotropin-releasing hormone agonist with GIFT achieved a high 51.9% clinical pregnancy rate and low cancellation rates.
Area of Science:
- Reproductive Endocrinology
- Infertility Treatments
- Assisted Reproductive Technologies
Background:
- Infertility affects a significant portion of the population.
- Gamete intrafallopian transfer (GIFT) is an assisted reproductive technology.
- Optimizing protocols for GIFT is crucial for improving success rates.
Purpose of the Study:
- To report on the clinical outcomes of the gamete intrafallopian transfer (GIFT) procedure.
- To evaluate the efficacy of gonadotropin-releasing hormone agonist in GIFT protocols.
- To assess the pregnancy and cancellation rates associated with this infertility treatment.
Main Methods:
- The study involved the application of the gamete intrafallopian transfer (GIFT) procedure.
- Gonadotropin-releasing hormone agonist was utilized as part of the treatment protocol.
- Clinical pregnancy rates and procedure cancellation rates were tracked.
Main Results:
- A clinical pregnancy rate of 51.9% was achieved.
- The utilization of gonadotropin-releasing hormone agonist was associated with the observed success.
- A low cancellation rate was reported for the GIFT procedure.
Conclusions:
- Gamete intrafallopian transfer (GIFT), when utilizing a gonadotropin-releasing hormone agonist, demonstrates significant efficacy in treating infertility.
- The protocol resulted in a high clinical pregnancy rate.
- The approach offers a promising option with a low cancellation rate for infertile patients.